Attached files

file filename
EX-3.1 - CERTIFICATE OF CHANGE - GeneSYS ID, Inc.f8k111215ex3i_rxsafesinc.htm

 

 

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): November 12, 2015

 

RX Safes, Inc.

 (Exact name of registrant as specified in its charter)

 

Nevada   333-193800   27-2928918
(State or other jurisdiction of
incorporation)
  (Commission
File Number)
  (I.R.S. Employer
Identification No.)

  

170 Green Valley Parkway, Suite 300

Henderson, NV

 

89012

(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: 702-800-4620

 

 

 

 (Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

 

 

 

SECTION 3 - SECURITIES AND TRADING MARKETS

 

Item 3.03 Material Modification of Rights of Security Holders

 

Our majority shareholders and our board of directors approved a reverse split of one to two hundred in which each shareholder of common stock will be issued one share of common stock in exchange for every two hundred shares of their currently issued common stock.

 

New stock certificates will be issued upon surrender of the shareholders’ old certificates.

 

A copy of the Certificate of Change that was filed with the Nevada Secretary of State on October 26, 2015 is attached hereto as Exhibit 3.1 and is incorporated by reference herein.

 

In connection with the reverse split, we have the following new CUSIP number: 78348J 204. We have submitted the required information to FINRA and received an effective date of November 12, 2015. Our common stock will be quoted under the symbol “RXSFD” for a period of 20 trading days. After 20 trading days, our common stock will resume trading under the symbol “RXSF.”

 

SECTION 5 – CORPORATE GOVERNANCE AND MANAGEMENT

 

Item 5.03 Amendments to Articles of Incorporation or Bylaws

 

The disclosures set forth in Item 3.03 are incorporated by reference into this Item 5.03.

 

SECTION 9 – FINANCIAL STATEMENTS AND EXHIBITS

 

Item 9.01 Financial Statements and Exhibits

 

Exhibit No.   Description
3.1   Certificate of Change

 

 2 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

RX Safes, Inc.

 

   
Lorraine Yarde  
CEO  
Date: November 12, 2015  

 

 

3